Search Results - "Viverette, F"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours by Tawbi, H A, Villaruz, L, Tarhini, A, Moschos, S, Sulecki, M, Viverette, F, Shipe-Spotloe, J, Radkowski, R, Kirkwood, J M

    Published in British journal of cancer (06-09-2011)
    “…Background: The DNA repair protein O 6 -methylguanine-DNA methyltransferase (MGMT) reverses the O 6 -methylguanine ( O 6 -meG) lesion induced by dacarbazine…”
    Get full text
    Journal Article
  2. 2

    The use of antithrombotic therapy in the elderly by Smith, T, Viverette, F, Adelman, B

    Published in Clinics in geriatric medicine (01-11-1985)
    “…The elderly are predisposed to atherosclerosis and venous thrombosis, the conditions for which anticoagulants are used. Anticoagulants can be used safely in…”
    Get more information
    Journal Article
  3. 3

    Phase I trial of lomeguatrib (PN) combined with dacarbazine (DTIC) for treatment of patients with melanoma and other solid tumors: Initial results by Tawbi, H., Tarhini, A., Moschos, S., Sulecki, M., Viverette, F., Radkowski, R., Shipe-Spotloe, J., Kunkel, C., Rae, M., Kirkwood, J.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 8016 Background: TheDNA repair enzyme O 6 -Alkylguanine Alkyltransferase (AGT) directly reverses the O 6 -methylguanine (O 6 -MeG) base lesion…”
    Get full text
    Journal Article